Terms: = Head and neck cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
425 results:
1. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
2. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
[TBL] [Abstract] [Full Text] [Related]
5. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
6. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
7. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.
Macagno N; Kervarrec T; Thanguturi S; Sohier P; Pissaloux D; Mescam L; Jullie ML; Frouin E; Osio A; Faisant M; Le Loarer F; Cribier B; Calonje E; Luna EVE; Massi D; Goto K; Nishida H; Paindavoine S; Houlier A; Tantot J; Benzerdjeb N; Tirode F; De la Fouchardière A; Battistella M
Mod Pathol; 2024 Mar; 37(3):100430. PubMed ID: 38266920
[TBL] [Abstract] [Full Text] [Related]
8. Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
Young RJ; Angel C; Bressel M; Pizzolla A; Thai AA; Porceddu SV; Liu H; Idrizi R; Metta J; Lim AM; Solomon BJ; Rischin D
Oral Oncol; 2024 Mar; 150():106687. PubMed ID: 38262249
[TBL] [Abstract] [Full Text] [Related]
9. Esketamine induces apoptosis of nasopharyngeal carcinoma cells through the PERK/chop pathway.
Cao Y; Li H; Gao Y; Long J; Zheng L; Zhang Q; Li N; Chi X
Toxicol Appl Pharmacol; 2024 Feb; 483():116800. PubMed ID: 38219984
[TBL] [Abstract] [Full Text] [Related]
10. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.
Gavrielatou N; Fortis E; Spathis A; Anastasiou M; Economopoulou P; Foukas GRP; Lelegiannis IM; Rusakiewicz S; Vathiotis I; Aung TN; Tissot S; Kastrinou A; Kotsantis I; Vagia EM; Panayiotides I; Rimm DL; Coukos G; Homicsko K; Foukas P; Psyrri A
Ann Oncol; 2024 Apr; 35(4):340-350. PubMed ID: 38159908
[TBL] [Abstract] [Full Text] [Related]
11. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
12. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract] [Full Text] [Related]
13. Mannose-doped metal-organic frameworks induce tumor cell pyroptosis via the PERK pathway.
Jin N; Wang B; Liu X; Yin C; Li X; Wang Z; Chen X; Liu Y; Bu W; Sun H
J Nanobiotechnology; 2023 Nov; 21(1):426. PubMed ID: 37968665
[TBL] [Abstract] [Full Text] [Related]
14. Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.
Kaiyrzhanov R; Rad A; Lin SJ; Bertoli-Avella A; Kallemeijn WW; Godwin A; Zaki MS; Huang K; Lau T; Petree C; Efthymiou S; Karimiani EG; Hempel M; Normand EA; Rudnik-Schöneborn S; Schatz UA; Baggelaar MP; Ilyas M; Sultan T; Alvi JR; Ganieva M; Fowler B; Aanicai R; Tayfun GA; Al Saman A; Alswaid A; Amiri N; Asilova N; Shotelersuk V; Yeetong P; Azam M; Babaei M; Monajemi GB; Mohammadi P; Samie S; Banu SH; Pinto Basto J; Kortüm F; Bauer M; Bauer P; Beetz C; Garshasbi M; Issa AH; Eyaid W; Ahmed H; Hashemi N; Hassanpour K; Herman I; Ibrohimov S; Abdul-Majeed BA; Imdad M; Isrofilov M; Kaiyal Q; Khan S; Kirmse B; Koster J; Lourenço CM; Mitani T; Moldovan O; Murphy D; Najafi M; Pehlivan D; Rocha ME; Salpietro V; Schmidts M; Shalata A; Mahroum M; Talbeya JK; Taylor RW; Vazquez D; Vetro A; Waterham HR; Zaman M; Schrader TA; Chung WK; Guerrini R; Lupski JR; Gleeson J; Suri M; Jamshidi Y; Bhatia KP; Vona B; Schrader M; Severino M; Guille M; Tate EW; Varshney GK; Houlden H; Maroofian R
Brain; 2024 Apr; 147(4):1436-1456. PubMed ID: 37951597
[TBL] [Abstract] [Full Text] [Related]
15. Acetylshikonin induces apoptosis through the endoplasmic reticulum stress-activated PERK/eIF
Yuan YJ; Liu S; Yang H; Xu JL; Zhai J; Jiang HM; Sun B
J Cell Mol Med; 2024 Jan; 28(1):e18030. PubMed ID: 37929884
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma.
Bao J; Betzler AC; Hess J; Brunner C
Front Immunol; 2023; 14():1233085. PubMed ID: 37868967
[TBL] [Abstract] [Full Text] [Related]
17. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in head and neck Squamous Cell Carcinoma.
Secrier M; McGrath L; Ng F; Gulati S; Raymond A; Nuttall BRB; Berthe J; Jones EV; Sidders BS; Galon J; Barrett JC; Angell HK
Cancer Res Commun; 2023 Oct; 3(10):2133-2145. PubMed ID: 37819239
[TBL] [Abstract] [Full Text] [Related]
18. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures.
Li H; Lin WP; Zhang ZN; Sun ZJ
Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247
[TBL] [Abstract] [Full Text] [Related]
19. A collision tumor of nasopharyngeal carcinoma and primary mantle cell lymphoma in the nasopharynx: a case report and review of the literature.
Jiang M; Yuan XP; Zhang H; Li CQ; Mao YL; Chen WL
BMC Oral Health; 2023 Sep; 23(1):672. PubMed ID: 37718438
[TBL] [Abstract] [Full Text] [Related]
20. [Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review].
Lv J; Yu T; Yin W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):755-758. PubMed ID: 37640999
[No Abstract] [Full Text] [Related]
[Next]
